Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
Baseline cognitive performance predicted future depression risk in opposite directions depending on depression history: lower cognition signaled higher risk in never-depressed controls, while higher cognition was associated with greater relapse risk in remitted depression, in a longitudinal UK Biobank analysis of 3,724 participants.
Internal Medicine June 9th 2026
News Medical
A narrative review of UCLA spice research found associations between common culinary spices — cinnamon, turmeric, red pepper, and spice blends — and glucose regulation, gut microbiome composition, and cognitive markers, though most findings stem from small trials and in vitro work using supratherapeutic doses.
Endocrinology, Diabetes, Metabolism June 8th 2026
Neurology Advisor
A machine learning sleep EEG score measured in midlife was associated with neuropsychological performance over a decade later in a Framingham cohort.
Neurology May 28th 2026
Alzheimer’s News Today
Blarcamesine (Anavex 2-73), an investigational once-daily oral autophagy enhancer, showed sustained cognitive, functional, and brain volume benefits through nearly 3 years in a Phase 2b/3 trial and open-label extension presented at AD/PD 2026.
Geriatrics May 14th 2026
Medical Xpress
A retrospective ADNI cohort analysis found that omega-3 supplement users showed faster cognitive decline over 5 years than matched non-users, with FDG-PET evidence of reduced brain glucose metabolism.
Family Medicine/General Practice May 14th 2026
MDLinx
Online wellness messaging is reframing nicotine pouches, gum, and patches as cognitive enhancers and dementia prevention tools, despite negative results from the larger MIND trial published in December 2025.
Cardiology May 14th 2026